MYTHS IN HYPERLIPIDIEMIA TREATMENT & ROLE OF PCSK9 INHIBITION

Prof. Ori Ben-Yehuda

Executive Director of the Clinical Trails Center (CTC) at the Cardiovascular Research Foundation (CRF) in New York